医药BD交易（Business Development）是医药企业通过海外许可授权、联合开发、并购等，实现研发成果商业化或市场扩张的合作模式，已成为中国创新药企业发展的重要驱动力之一。

华海药业 ( 24.170, 2.20, 10.01%) 已经反复说HB0025寻求BD了多次。但这并未唤醒资本，且完整错过了这一轮创新药行情，企业市值一直在330亿附近徘徊，市盈率29倍左右。

消息面上，1) 晶泰控股25H1营收同比增长403.8%，药物发现业务受益于与DoveTree的5100万美元合作及全球TOP20药企订单，机器人业务因"灵动勺"及百万美元级订单增长95.9%；2) 君实生物上半年研发投入增长18%，核心产品销售收入 ...

Sam McKewon breaks down Nebraska football's win over Cincinnati in his Eyman Big Red Truck Recap on Thursday, Aug. 28, 2025.

Noah Lyles warmed up for the upcoming athletics world championships by chasing down Olympic champion Letsile Tebogo to win ...

Japanese officials have released AI-generated videos simulating a potential eruption of Mount Fuji. The videos, unveiled this ...

Sacramento Kings guard Dennis Schroder has scored a game-high 23 points and made seven assists to lead world champion Germany ...

HOUSTON — A disabled Navy veteran in northwest Houston is finally getting some relief after being without running water in his home for more than two weeks. Roy Williamson said he shut off his water ...

According to an official release, the draft report has been publicly available since 24 August last and can be found on the websites of the Ministry of Water Resources ( and the Bangladesh Haor and We ...

Lula A. Webber died following a vehicle crash involving a Florence County Sheriff’s deputy at the intersection of Pamplico Highway and Willow Creek Road.

泰恩康董事长郑汉杰在接受《每日经济新闻》记者专访时表示，创新药出海目前真正成功的概率只有1%，门槛很高。他提出了“双背书”方案，即国家层面的突破性疗法认定和学术层面的顶级期刊论文发表。谈及未来的并购策略，郑汉杰的思路很清晰，“聚焦批文、而非药厂”。他表示，2025年是泰恩康的“突破元年”，今年年底到明年，公司的三类新药和创新药管线会陆续进入收获期。

Here are six U.S. properties where players can be courtside right after their morning coffee.